{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:46:33Z","timestamp":1793043993035,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15H01517, 15K15608"],"award-info":[{"award-number":["15H01517, 15K15608"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26462529, 17K11280"],"award-info":[{"award-number":["26462529, 17K11280"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FUKUOKA OBGYN Researcher\u2019s Charity Foundation Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Matricellular glycoprotein, SPARC is a secreted molecule, that mediates the interaction between cells and extracellular matrix. SPARC functions as a regulator of matrix organization and modulates cell behavior. In various kinds of cancer, strong SPARC expression was observed in stromal tissues as well as in cancer epithelial cells. The function of SPARC in cancer cells is somewhat controversial and its impact on peritumoral stromal cells remains to be resolved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated the effects of SPARC expression in endometrial cancer cells on the surrounding stromal fibroblasts using in vitro co-culture system. Changes in characteristics of fibroblasts were examined by analysis of fibroblast-specific markers and in vitro contraction assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SPARC induced AKT phosphorylation and epithelial-to-mesenchymal transition, consistent with previous reports. Cancer-associated fibroblasts of endometrial cancer expressed higher levels of mesenchymal- and fibroblast-associated factors and had a stronger contraction ability. Unexpectedly, cancer-associated fibroblasts expressed comparable levels of SPARC compared with fibroblasts from normal endometrium. However, co-culture of normal fibroblasts with SPARC-expressing Ishikawa cells resulted in activation of the fibroblasts. Immunodepletion of SPARC did not affect the activation of fibroblasts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data indicated that SPARC activated fibroblasts only in the presence of fibronectin, which was abundantly secreted from SPARC-expressing endometrial cancer cells. These results suggested that a SPARC-fibronectin-mediated activation of fibroblasts might be involved in enhanced mobility and invasion of cancer cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-07875-9","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T15:30:21Z","timestamp":1613143821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Fibronectin mediates activation of stromal fibroblasts by SPARC in endometrial cancer cells"],"prefix":"10.1186","volume":"21","author":[{"given":"Sachiko","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4921-2859","authenticated-orcid":false,"given":"Kazuo","family":"Asanoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Onoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Okugawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Yahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"key":"7875_CR1","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/carcin\/bgu072","volume":"35","author":"GP Nagaraju","year":"2014","unstructured":"Nagaraju GP, Dontula R, El-Rayes BF, et al. Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis. Carcinogenesis. 2014;35:967\u201373.","journal-title":"Carcinogenesis."},{"key":"7875_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bph.13653","volume":"174","author":"SL Wong","year":"2017","unstructured":"Wong SL, Sukkar MB. The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease. Br J Pharmacol. 2017;174:3\u201314.","journal-title":"Br J Pharmacol"},{"key":"7875_CR3","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.1158\/0008-5472.CAN-05-3189","volume":"66","author":"G Robert","year":"2006","unstructured":"Robert G, Gaggioli C, Bailet O, et al. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development. Cancer Res. 2006;66:7516\u201323.","journal-title":"Cancer Res"},{"key":"7875_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040378","volume":"7","author":"N Fenouille","year":"2012","unstructured":"Fenouille N, Tichet M, Dufies M, et al. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion. PLoS One. 2012;7:e40378.","journal-title":"PLoS One"},{"key":"7875_CR5","doi-asserted-by":"publisher","first-page":"63691","DOI":"10.18632\/oncotarget.19475","volume":"8","author":"JY Hung","year":"2017","unstructured":"Hung JY, Yen MC, Jian SF, et al. Secreted protein acidic and rich in cysteine (SPARC) induces cell migration and epithelial mesenchymal transition through WNK1\/snail in non-small cell lung cancer. Oncotarget. 2017;8:63691\u2013702.","journal-title":"Oncotarget."},{"key":"7875_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1006\/gyno.1999.5552","volume":"75","author":"TJ Brown","year":"1999","unstructured":"Brown TJ, Shaw PA, Karp X, et al. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer. Gynecol Oncol. 1999;75:25\u201333.","journal-title":"Gynecol Oncol"},{"key":"7875_CR7","first-page":"1301","volume":"17","author":"FJ Rodriguez-Jimenez","year":"2007","unstructured":"Rodriguez-Jimenez FJ, Caldes T, Iniesta P, et al. Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma. Oncol Rep. 2007;17:1301\u20137.","journal-title":"Oncol Rep"},{"key":"7875_CR8","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1038\/sj.onc.1206807","volume":"22","author":"N Sato","year":"2003","unstructured":"Sato N, Fukushima N, Maehara N, et al. SPARC\/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions. Oncogene. 2003;22:5021\u201330.","journal-title":"Oncogene."},{"key":"7875_CR9","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/pros.22664","volume":"73","author":"M Shin","year":"2013","unstructured":"Shin M, Mizokami A, Kim J, et al. Exogenous SPARC suppresses proliferation and migration of prostate cancer by interacting with integrin beta1. Prostate. 2013;73:1159\u201370.","journal-title":"Prostate."},{"key":"7875_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1200\/JCO.2006.07.8824","volume":"25","author":"JR Infante","year":"2007","unstructured":"Infante JR, Matsubayashi H, Sato N, et al. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. J Clin Oncol. 2007;25:319\u201325.","journal-title":"J Clin Oncol"},{"key":"7875_CR11","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1084\/jem.20030202","volume":"198","author":"S Sangaletti","year":"2003","unstructured":"Sangaletti S, Stoppacciaro A, Guiducci C, et al. Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma. J Exp Med. 2003;198:1475\u201385.","journal-title":"J Exp Med"},{"key":"7875_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1172\/JCI16804","volume":"111","author":"RA Brekken","year":"2003","unstructured":"Brekken RA, Puolakkainen P, Graves DC, et al. Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. J Clin Invest. 2003;111:487\u201395.","journal-title":"J Clin Invest"},{"key":"7875_CR13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1158\/1541-7786.215.2.4","volume":"2","author":"PA Puolakkainen","year":"2004","unstructured":"Puolakkainen PA, Brekken RA, Muneer S, et al. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. Mol Cancer Res. 2004;2:215\u201324.","journal-title":"Mol Cancer Res"},{"key":"7875_CR14","doi-asserted-by":"publisher","first-page":"9050","DOI":"10.1158\/0008-5472.CAN-08-1327","volume":"68","author":"S Sangaletti","year":"2008","unstructured":"Sangaletti S, Di Carlo E, Gariboldi S, et al. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. Cancer Res. 2008;68:9050\u20139.","journal-title":"Cancer Res"},{"key":"7875_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1242\/dmm.003228","volume":"3","author":"SA Arnold","year":"2010","unstructured":"Arnold SA, Rivera LB, Miller AF, et al. Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma. Dis Model Mech. 2010;3:57\u201372.","journal-title":"Dis Model Mech"},{"key":"7875_CR16","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.2353\/ajpath.2007.060903","volume":"170","author":"N Said","year":"2007","unstructured":"Said N, Najwer I, Motamed K. Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer. Am J Pathol. 2007;170:1054\u201363.","journal-title":"Am J Pathol"},{"key":"7875_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1172\/JCI71241","volume":"123","author":"N Said","year":"2013","unstructured":"Said N, Frierson HF, Sanchez-Carbayo M, et al. Loss of SPARC in bladder cancer enhances carcinogenesis and progression. J Clin Invest. 2013;123:751\u201366.","journal-title":"J Clin Invest"},{"key":"7875_CR18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.0022-202X.2004.23316.x","volume":"123","author":"RL Aycock","year":"2004","unstructured":"Aycock RL, Bradshaw AC, Sage EH, et al. Development of UV-induced squamous cell carcinomas is suppressed in the absence of SPARC. J Invest Dermatol. 2004;123:592\u20139.","journal-title":"J Invest Dermatol"},{"key":"7875_CR19","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1136\/gut.2006.116921","volume":"56","author":"OJ Sansom","year":"2007","unstructured":"Sansom OJ, Mansergh FC, Evans MJ, et al. Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin\/+ mice. Gut. 2007;56:1410\u20134.","journal-title":"Gut."},{"key":"7875_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10585-007-9126-2","volume":"25","author":"SY Wong","year":"2008","unstructured":"Wong SY, Crowley D, Bronson RT, et al. Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer. Clin Exp Metastasis. 2008;25:109\u201318.","journal-title":"Clin Exp Metastasis"},{"key":"7875_CR21","doi-asserted-by":"publisher","first-page":"37849","DOI":"10.1074\/jbc.M302946200","volume":"278","author":"EH Sage","year":"2003","unstructured":"Sage EH, Reed M, Funk SE, et al. Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis. J Biol Chem. 2003;278:37849\u201357.","journal-title":"J Biol Chem"},{"key":"7875_CR22","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2353\/ajpath.2009.080906","volume":"175","author":"I Podgorski","year":"2009","unstructured":"Podgorski I, Linebaugh BE, Koblinski JE, et al. Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis. Am J Pathol. 2009;175:1255\u201369.","journal-title":"Am J Pathol"},{"key":"7875_CR23","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/jcb.21688","volume":"104","author":"CJ Clark","year":"2008","unstructured":"Clark CJ, Sage EH. A prototypic matricellular protein in the tumor microenvironment--where there's SPARC, there's fire. J Cell Biochem. 2008;104:721\u201332.","journal-title":"J Cell Biochem"},{"key":"7875_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ygyno.2014.04.009","volume":"134","author":"N Yusuf","year":"2014","unstructured":"Yusuf N, Inagaki T, Kusunoki S, et al. SPARC was overexpressed in human endometrial cancer stem-like cells and promoted migration activity. Gynecol Oncol. 2014;134:356\u201363.","journal-title":"Gynecol Oncol"},{"key":"7875_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/biolre\/ioaa044","volume":"103","author":"H Tomari","year":"2020","unstructured":"Tomari H, Kawamura T, Asanoma K, et al. Contribution of senescence in human endometrial stromal cells during proliferative phase to embryo receptivity\u2020. Biol Reprod. 2020;103:104\u201313.","journal-title":"Biol Reprod"},{"key":"7875_CR26","doi-asserted-by":"publisher","first-page":"112113","DOI":"10.1016\/j.yexcr.2020.112113","volume":"394","author":"N Zhang","year":"2020","unstructured":"Zhang N, Wang Y, Liu H, et al. Extracellular vesicle encapsulated microRNA-320a inhibits endometrial cancer by suppression of the HIF1\u03b1\/VEGFA axis. Exp Cell Res. 2020;394:112113.","journal-title":"Exp Cell Res"},{"key":"7875_CR27","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1038\/onc.2012.351","volume":"32","author":"O Aprelikova","year":"2013","unstructured":"Aprelikova O, Palla J, Hibler B, et al. Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility. Oncogene. 2013;32:3246\u201353.","journal-title":"Oncogene."},{"key":"7875_CR28","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.4161\/cc.9.21.13674","volume":"9","author":"O Aprelikova","year":"2010","unstructured":"Aprelikova O, Yu X, Palla J, et al. The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle. 2010;9:4387\u201398.","journal-title":"Cell Cycle"},{"key":"7875_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068923","volume":"8","author":"KS Subramaniam","year":"2013","unstructured":"Subramaniam KS, Tham ST, Mohamed Z, et al. Cancer-associated fibroblasts promote proliferation of endometrial cancer cells. PLoS One. 2013;8:e68923.","journal-title":"PLoS One"},{"key":"7875_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13045-015-0231-4","volume":"9","author":"F Teng","year":"2016","unstructured":"Teng F, Tian WY, Wang YM, et al. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1\/CXCR4 axis. J Hematol Oncol. 2016;9:8.","journal-title":"J Hematol Oncol"},{"key":"7875_CR31","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ajpath.2017.11.008","volume":"188","author":"T Ohmaru-Nakanishi","year":"2018","unstructured":"Ohmaru-Nakanishi T, Asanoma K, Fujikawa M, et al. Fibrosis in Preeclamptic placentas is associated with stromal fibroblasts activated by the transforming growth factor-\u03b21 signaling pathway. Am J Pathol. 2018;188:683\u201395.","journal-title":"Am J Pathol"},{"key":"7875_CR32","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1128\/MCB.00678-15","volume":"35","author":"K Asanoma","year":"2015","unstructured":"Asanoma K, Liu G, Yamane T, et al. Regulation of the mechanism of TWIST1 transcription by BHLHE40 and BHLHE41 in Cancer cells. Mol Cell Biol. 2015;35:4096\u2013109.","journal-title":"Mol Cell Biol"},{"key":"7875_CR33","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398.","journal-title":"Nat Rev Cancer"},{"key":"7875_CR34","doi-asserted-by":"publisher","first-page":"52200","DOI":"10.1074\/jbc.M409630200","volume":"279","author":"Q Shi","year":"2004","unstructured":"Shi Q, Bao S, Maxwell JA, et al. Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation. J Biol Chem. 2004;279:52200\u20139.","journal-title":"J Biol Chem"},{"key":"7875_CR35","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1038\/sj.onc.1210181","volume":"26","author":"Q Shi","year":"2007","unstructured":"Shi Q, Bao S, Song L, et al. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases. Oncogene. 2007;26:4084\u201394.","journal-title":"Oncogene."},{"key":"7875_CR36","first-page":"5376","volume":"63","author":"MI Koukourakis","year":"2003","unstructured":"Koukourakis MI, Giatromanolaki A, Brekken RA, et al. Enhanced expression of SPARC\/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia\/acidity and with poor prognosis of patients. Cancer Res. 2003;63:5376\u201380.","journal-title":"Cancer Res"},{"key":"7875_CR37","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.4161\/cbt.7.11.6846","volume":"7","author":"TS Mantoni","year":"2008","unstructured":"Mantoni TS, Schendel RR, Rodel F, et al. Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma. Cancer Biol Ther. 2008;7:1806\u201315.","journal-title":"Cancer Biol Ther"},{"key":"7875_CR38","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ijc.21357","volume":"118","author":"A Chlenski","year":"2006","unstructured":"Chlenski A, Liu S, Guerrero LJ, et al. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix. Int J Cancer. 2006;118:310\u20136.","journal-title":"Int J Cancer"},{"key":"7875_CR39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.celrep.2016.08.075","volume":"17","author":"S Sangaletti","year":"2016","unstructured":"Sangaletti S, Tripodo C, Santangelo A, et al. Mesenchymal transition of high-grade breast carcinomas depends on extracellular matrix control of myeloid suppressor cell activity. Cell Rep. 2016;17:233\u201348.","journal-title":"Cell Rep"},{"key":"7875_CR40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/stem.3100","volume":"38","author":"J Zhu","year":"2020","unstructured":"Zhu J, Wang LY, Li CY, et al. SPARC promotes self-renewal of limbal epithelial stem cells and ocular surface restoration through JNK and p38-MAPK signaling pathways. Stem Cells. 2020;38:134\u201345.","journal-title":"Stem Cells"},{"key":"7875_CR41","doi-asserted-by":"publisher","first-page":"19351","DOI":"10.1074\/jbc.M116.737379","volume":"291","author":"S Sharma","year":"2016","unstructured":"Sharma S, Xing F, Liu Y, et al. Secreted protein acidic and rich in cysteine (SPARC) mediates metastatic dormancy of prostate Cancer in bone. J Biol Chem. 2016;291:19351\u201363.","journal-title":"J Biol Chem"},{"key":"7875_CR42","doi-asserted-by":"crossref","unstructured":"Salzer MC, Lafzi A, Berenguer-Llergo A et al. Identity Noise and Adipogenic Traits Characterize Dermal Fibroblast Aging. Cell. 2018; 175: 1575\u20131590.e1522.","DOI":"10.1016\/j.cell.2018.10.012"},{"key":"7875_CR43","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/ar3010","volume":"12","author":"E Neumann","year":"2010","unstructured":"Neumann E, Riepl B, Knedla A, et al. Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther. 2010;12:R83.","journal-title":"Arthritis Res Ther"},{"key":"7875_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052032","volume":"7","author":"K Dawson","year":"2012","unstructured":"Dawson K, Wu CT, Qi XY, et al. Congestive heart failure effects on atrial fibroblast phenotype: differences between freshly-isolated and cultured cells. PLoS One. 2012;7:e52032.","journal-title":"PLoS One"},{"key":"7875_CR45","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/onc.2009.463","volume":"29","author":"M Bauer","year":"2010","unstructured":"Bauer M, Su G, Casper C, et al. Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast. Oncogene. 2010;29:1732\u201340.","journal-title":"Oncogene."},{"key":"7875_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/pros.2990270108","volume":"27","author":"A Kooistra","year":"1995","unstructured":"Kooistra A, Elissen NM, K\u00f6nig JJ, et al. Immunocytochemical characterization of explant cultures of human prostatic stromal cells. Prostate. 1995;27:42\u20139.","journal-title":"Prostate."},{"key":"7875_CR47","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ygyno.2013.03.005","volume":"129","author":"S Kusunoki","year":"2013","unstructured":"Kusunoki S, Kato K, Tabu K, et al. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells. Gynecol Oncol. 2013;129:598\u2013605.","journal-title":"Gynecol Oncol"},{"key":"7875_CR48","doi-asserted-by":"publisher","first-page":"36483","DOI":"10.1074\/jbc.M504663200","volume":"280","author":"TH Barker","year":"2005","unstructured":"Barker TH, Baneyx G, Cardo-Vila M, et al. SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem. 2005;280:36483\u201393.","journal-title":"J Biol Chem"},{"key":"7875_CR49","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/glia.20679","volume":"56","author":"WA Golembieski","year":"2008","unstructured":"Golembieski WA, Thomas SL, Schultz CR, et al. HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion. Glia. 2008;56:1061\u201375.","journal-title":"Glia."},{"key":"7875_CR50","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/neuonc\/nos326","volume":"15","author":"R Alam","year":"2013","unstructured":"Alam R, Schultz CR, Golembieski WA, et al. PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma. Neuro-Oncology. 2013;15:451\u201361.","journal-title":"Neuro-Oncology"},{"key":"7875_CR51","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ctrv.2010.12.001","volume":"37","author":"GP Nagaraju","year":"2011","unstructured":"Nagaraju GP, Sharma D. Anti-cancer role of SPARC, an inhibitor of adipogenesis. Cancer Treat Rev. 2011;37:559\u201366.","journal-title":"Cancer Treat Rev"},{"key":"7875_CR52","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1172\/JCI12609","volume":"107","author":"JE Murphy-Ullrich","year":"2001","unstructured":"Murphy-Ullrich JE. The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest. 2001;107:785\u201390.","journal-title":"J Clin Invest"},{"key":"7875_CR53","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental KR, Yu H, Kass L, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139:891\u2013906.","journal-title":"Cell."},{"key":"7875_CR54","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ccr.2009.11.013","volume":"16","author":"MR Ng","year":"2009","unstructured":"Ng MR, Brugge JS. A stiff blow from the stroma: collagen crosslinking drives tumor progression. Cancer Cell. 2009;16:455\u20137.","journal-title":"Cancer Cell"},{"key":"7875_CR55","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1038\/jid.2011.239","volume":"131","author":"MR Girotti","year":"2011","unstructured":"Girotti MR, Fernandez M, Lopez JA, et al. SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I\/alpha2beta1 integrin axis. J Invest Dermatol. 2011;131:2438\u201347.","journal-title":"J Invest Dermatol."},{"key":"7875_CR56","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/acel.12168","volume":"13","author":"K Nakamura","year":"2014","unstructured":"Nakamura K, Yamanouchi K, Nishihara M. Secreted protein acidic and rich in cysteine internalization and its age-related alterations in skeletal muscle progenitor cells. Aging Cell. 2014;13:175\u201384.","journal-title":"Aging Cell"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07875-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-021-07875-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07875-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T21:31:22Z","timestamp":1671226282000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-07875-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["7875"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-07875-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]},"assertion":[{"value":"20 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from all patients. The study was approved by the Ethical Committee of Kyushu University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}